Health Insurance (Variation of Fees and Medical Services) (No. 12) Regulations (Cth)

Case
No judgment structure available for this case.

Statutory Rules

1979 No. 35

REGULATIONS UNDER THE HEALTH INSURANCE ACT 19731

I, THE GOVERNOR-GENERAL of the Commonwealth of Australia acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Health Insurance Act 1973.

Dated this first day of March 1979.

ZELMAN COWEN

Governor-General

By His Excellency’s Command,

RALPH J. HUNT

Minister of State for Health

–––––––––

HEALTH INSURANCE (VARIATION OF FEES AND MEDICAL SERVICES) (No. 12) REGULATIONS

Citation

1. These Regulations may be cited as the Health Insurance (Variation of Fees and Medical Services) (No. 12) Regulations.

Commencement

2. These Regulations shall come into operation on 5 March 1979.

Health Insurance (Variation of Fees and Medical Services) (No. 7) Regulations— amendment of Schedule

3. The Schedule to the Health Insurance (Variation of Fees and Medical Services) (No. 7) Regulations (being that Schedule as amended by the Health Insurance (Variation of Fees and Medical Services) (No. 8) Regulations, the Health Insurance (Variation of Fees and Medical Services) (No. 9) Regulations, the Health Insurance (Variation of Fees and Medical Services) (No. 10) Regulations and the Health Insurance (Variation of Fees and Medical Services) (No. 11) Regulations) is amended by omitting Part 7 of the table of medical services and substituting the following Part:

 

“PART 7—PATHOLOGY SERVICES

Item No.

Fees

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“Division 1—Haematology

“1006

Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—one procedure (SP)............

3.20

3.20

3.20

3.20

3.20

3.20

“1007

Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—one procedure (excluding blood count consisting of haemoglobin estimation or erythrocyte sedimentation rate when not referred by another medical practitioner) (OP)............................

2.40

2.40

2.40

2.40

2.40

2.40

“1008

2 procedures to which item 1006 applies (SP)....

5.10

5.10

5.10

5.10

5.10

5.10

“1009

2 procedures to which item 1007 applies (OP)...

3.85

3.85

3.85

3.85

3.85

3.85

“1010

Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—two procedures (excluding blood count consisting of haemoglobin estimation or erythrocyte sedimentation rate when not referred by another medical practitioner) (HP)............................

3.25

3.25

3.25

3.25

3.25

3.25

“1011

3 or more procedures to which item 1006 applies including calculation of erythrocyte indices where done (SP).............

7.70

7.70

7.70

7.70

7.70

7.70

“1012

3 or more procedures to which item 1007 applies including calculation of erythrocyte indices where done (OP).............

5.80

5.80

5.80

5.80

5.80

5.80

“1013

3 or more procedures to which item 1010 applies, including calculation of erythrocyte indices where done (HP).............

3.85

3.85

3.85

3.85

3.85

3.85

“1014

Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (SP)...........................................................

6.40

6.40

6.40

6.40

6.40

6.40

“1015

Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (OP)...........................................................

4.80

4.80

4.80

4.80

4.80

4.80

“1016

Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (HP)...........................................................

3.20

3.20

3.20

3.20

3.20

3.20

“1019

Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes or similar conditions, cells or substances-one procedure (SP)............................................

2.60

2.60

2.60

2.60

2.60

2.60

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1020

Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes, or similar conditions, cells or substances—one procedure (OP)...............

1.95

1.95

1.95

1.95

1.95

1.95

“1021

2 or more procedures to which item 1019 applies (SP) 

3.90

3.90

3.90

3.90

3.90

3.90

“1022

2 or more procedures to which item 1020 applies (OP) 

2.95

2.95

2.95

2.95

2.95

2.95

“1028

Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-one procedure (SP)....................

3.90

3.90

3.90

3.90

3.90

3.90

“1029

Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-one procedure (OP)....................

2.95

2.95

2.95

2.95

2.95

2.95

“1030

2 or more procedures to which item 1028 applies (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1032

2 or more procedures to which item 1029 applies (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“1036

Erythrocytes, qualitative assessment of metabolism or haemolysis by— erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical), glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria—one procedure (SP)........................................................

6.40

6.40

6.40

6.40

6.40

6.40

“1037

Erythrocytes, qualitative assessment of metabolism or haemolysis by— erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical), glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria— one procedure (OP).......................................................

4.80

4.80

4.80

4.80

4.80

4.80

“1038

2 or more procedures to which item 1036 applies (SP) 

12.80

12.80

12.80

12.80

12.80

12.80

“1040

2 or more procedures to which item 1037 applies (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1044

Erythrocytes, quantitative assessment of metabolism or haemolysis by-acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation or pyruvate kinase estimation -one procedure (SP)..........

12.80

12.80

12.80

12.80

12.80

12.80

“1045

Erythrocytes, quantitative assessment of metabolism or haemolysis by-acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation or pyruvate kinase estimation-one procedure (OP)..........

9.60

9.60

9.60

9.60

9.60

9.60

“1048

2 or more procedures to which item 1044 applies (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

“1049

2 or more of any procedures to which item 1045 applies (OP) 

19.15

19.15

19.15

19.15

19.15

19.15

“Bone Marrow Examination

“1062

Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-one procedure (SP)..........................................................

38.50

38.50

38.50

38.50

38.50

38.50

“1063

Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-one procedure (OP)..........................................................

28.90

28.90

28.90

28.90

28.90

28.90

“1064

2 or more procedures to which item 1062 applies (SP) 

64.00

64.00

64.00

64.00

64.00

64.00

“1065

2 or more procedures to which item 1063 applies (OP) 

48.00

48.00

48.00

48.00

48.00

48.00

"Blood Transfusion Procedures

“1080

Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) (not covered by item 1089) (SP)......

6.40

6.40

6.40

6.40

6.40

6.40

“1081

Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) (not covered by item 1090) (OP).....

4.80

4.80

4.80

4.80

4.80

4.80

“1089

Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) when performed in association with the compatibility testing covered by item 1112 or 1114 (SP)..............

11.60

11.60

11.60

11.60

11.60

11.60

“1090

Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) when performed in association with the compatibility testing covered by item 1113 or 1116 (OP).............

8.70

8.70

8.70

8.70

8.70

8.70

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1101

Blood grouping—for Rh phenotypes or grouping by the Kell, Duffy or any other blood group system—one procedure (SP)............................................................

12.80

12.80

12.80

12.80

12.80

12.80

“1102

Blood grouping—for Rh phenotypes or grouping by the Kell, Duffy or any other blood group system—one procedure (OP)............................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1104

2 procedures to which item 1101 applies (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

“1105

2 procedures to which item 1102 applies (OP )

19.15

19.15

19.15

19.15

19.15

19.15

“1106

Each procedure to which item 1101 applies in excess of 2 (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1108

Each procedure to which item 1102 applies in excess of 2 (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“1111

Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—testing involving one or two units of blood (SP) 

25.50

25.50

25.50

25.50

25.50

23-50

“1112

Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—testing involving one or two units of blood (OP) 

19.15

19.15

19.15

19.15

19.15

19.15

“1113

Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—testing involving one or two units of blood (HP) 

12.75

12.75

12.75

12.75

12.75

12.75

“1114

Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of 2 (SP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1116

Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of 2 (OP) 

7.20

7.20

7.20

7.20

7.20

7.20

“1117

Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of 2 (HP) 

4.80

4.80

4.80

4.80

4.80

4.80

“1121

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) (SP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1122

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) (OP) 

7.20

7.20

7.20

7.20

7.20

7.20

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

“1124

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) and quantitative estimation of one antibody (SP)..................................

25.50

25.50

25.50

25.50

25.50

25.50

“1125

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) and quantitative estimation of one antibody (OP).................................

19.15

19.15

19.15

19.15

19.15

19.15

“1126

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of one antibody (SP)..............

19.20

19.20

19.20

19.20

19.20

19.20

“1128

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of one antibody (OP)..............

14.40

14.40

14.40

14.40

14.40

14.40

“1129

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of each antibody in excess of one (SP) 

12.80

12.80

12.80

12.80

12.80

12.80

“1130

Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of each antibody in excess of one (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1136

Coombs test, direct (SP)............................

6.40

6.40

6.40

6.40

6.40

6.40

“1137

Coombs test, direct (OP)...........................

4.80

4.80

4.80

4.80

4.80

4.80

“1144

Coombs test, indirect (not associated with item 1112, 1114, 1121, 1124, 1126 or 1129 except where part of neo-natal screening or in investigation of haemolytic anaemia) (SP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1145

Coombs test, indirect (not associated with item 1113, 1116, 1122, 1125, 1128 or 1130 except where part of neo-natal screening or in investigation of haemolytic anaemia) (OP) 

7.20

7.20

7.20

7.20

7.20

7.20

“1152

Examination of serum for blood group haemolysins (SP) 

12.80 1

12.80

12.80

12.80

12.80

12.80

“1153

Examination of serum for blood group haemolysins (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1159

Leucocyte agglutinins, detection of (SP).....

12.80 1

12.80

12.80

12.80

12.80

12.80

“1160

Leucocyte agglutinins, detection of (OP).....

9.60

9.60

9.60

9.60

9.60

9.60

“1166

Platelet agglutinins, detection of (SP)..........

12.80 1

12.80

12.80

12.80

12.80

12.80

“1167

Platelet agglutinins, detection of (OP).........

9.60

9.60

9.60

9.60

9.60

9.60

“1190

Heterophile antibodies—qualitative estimation of (test for infectious mononucleosis) (SP)...............

5.10

5.10

5.10

5.10

5.10

5.10

“1191

Heterophile antibodies-qualitative estimation of (test for infectious mononucleosis) (OP).............................

3.85

3.85

3.85

3.85

3.85

3.85

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1194

Heterophile antibodies—quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by item 1190 where performed) (SP).............

12.80

12.80

12.80

12.80

12.80

12.80

“1195

Heterophile antibodies—quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by item 1191 where performed) (OP).............

9.60

9.60

9.60

9.60

9.60

9.60

“1202

Cold agglutinins, qualitative estimation of (SP) 

5.10

5.10

5.10

5.10

5.10

5.10

“1203

Cold agglutinins, qualitative estimation of (OP) 

3.85

3.85

3.85

3.85

3.85

3.85

“1206

Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by item 1202 where performed) (SP)..............................................................

12.80

12.80

12.80

12.80

12.80

12.80

“1207

Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by item 1203 where performed) (OP)..............................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1211

Bipod volume, estimation of by dye method (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1212

Blood volume, estimation of by dye method (OP) 

4.80

4.80

4.30

4.80

4.80

4.80

“1215

Blood, spectroscopic examination of (SP).....

6.40

6.40

6.40

6.40

6.40

6.40

“1216

Blood,, spectroscopic examination of (OP)....

4.80

4.80

4.80

4.80

4.80

4.80

“Haemostasis

“1234

Estimation of—bleeding time, coagulation time (including clot retraction), prothrombin time (one stage) or thromboplastin time (partial) with or without kaolin or kaolin clotting time-one procedure (SP)........................................................

6.40

6.40

6.40

6.40

6.40

6.40

“1235

Estimation of—bleeding time, coagulation time (including clot retraction), prothrombin time (one stage) or thromboplastin time (partial) with or without kaolin or kaolin clotting time-one procedure (OP).......................................................

4.80

4.80

4.80

4.80

4.80

4.80

“1236

2 procedures to which item 1234 applies (SP)

9.60

9.60

9.60

9.60

9.60

9.60

“1237

2 procedures to which item 1235 applies (OP)

7.20

7.20

7.20

7.20

7.20

7.20

“1238

3 or more procedures to which item 1234 applies (SP) 

12.80

12.80

12.80

12.80

12.80,

12.80

“1239

3 or more procedures to which item 1235 applies (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1242

Platelet aggregation, qualitative test for (SP)..

6.40

6.40

6.40

6.40

6.40

6.40

“1243

Platelet aggregation, qualitative test for (OP).

4.80

4.80

4.80

4.80

4.80

4.80

“1244

Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time—each procedure (SP).......................

6.40

6.40

6.40

6.40

6.40

6.40

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1246

Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time—each procedure (OP)..........................................

4.80

4.80

4.80

4.80

4.80

4.80

“1247

Fibrinogen litre, determination of (SP).............

6.40

6.40

6.40

6.40

6.40

6.40

“1248

Fibrinogen titre, determination of (OP)............

4.80

4.80

4.80

4.80

4.80

4.80

“1251

Factor 13, test for presence of (SP)..................

9.60

9.60

9.60

9.60

9.60

9.60

“1252

Factor 13, test for presence of (OP).................

7.20

7.20

7.20

7.20

7.20

7.20

“1255

Thromboplastin generation screening test (SP)..

9.60

9.60

9.60

9.60

9.60

9.60.

“1256

Thromboplastin generation screening test (OP).

7.20

7.20

7.20

7.20

7.20

7.20

“1259

Prothrombin time, estimation of (two stage) (SP)

9.60

9.60

9.60

9.60

9.60

9.60

“1260

Prothrombin time, estimation of (two stage) (OP) 

7.20

7.20

7.20

7.20

7.20

7.20

“1263

Quantitative estimation of—fibrin degeneration products, platelet adhesion, prothrombin consumption or protamine sulphate—each procedure (SP).................................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1264

Quantitative estimation of—fibrin degeneration products, platelet adhesion, prothrombin consumption or protamine sulphate—each procedure (OP).................................................................

7.20

7.20

7.20

7.20

7.20

7.20

“1267

Euglobulin lysis time, estimation of (SP)..........

19.20

19.20

19.20

19.20

19.20

19.20

“1268

Euglobulin lysis time, estimation of (OP).........

14.40

14.40

14.40

14.40

14.40

14.40

“1271

Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)— each procedure (SP) 

19.20

19.20

19.20

19.20

19.20

19.20

“1272

Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)— each procedure (OP)

14.40

14.40

14.40

14.40

14.40

14.40

“1277

Platelet aggregation test using—ADP, collagen, 5HT, ristocetin, or similar substance—one procedure (SP)....................

19.20

19.20

19.20

19.20

19.20

19.20

“1278

Platelet aggregation test using—ADP, collagen, 5HT, ristocetin, or similar substance—one procedure (OP)...................

14.40

14.40

14.40

14.40

14.40

14.40

“1279

2 or more procedures to which item 1277 applies (SP) 

38.50

38.50

38.50

38.50

38.50

38.50

“1280

2 or more procedures to which item 1278 applies (OP) 

28.90

28.90

28.90

28.90

28.90

28.90

“Division 2—Chemistry of Body Fluids and Tissues

“1301

Estimation by any method of—albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than items 1302 and 1303 where the estimation is performed on a multichannel analyser-one estimation (SP)....

9.60

9.60

9.60

9.60

9.60

9.60

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1302

Estimation by any method of-albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than items 1301 and 1303 where the estimation is performed on a multi- channel analyser-one estimation (OP)........................

7.20

7.20

7.20

7.20

7.20

7.20

“1303

Estimation by any method of-albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin, (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than items 1301 and 1302 where the estimation is performed on a multi- channel analyser-one estimation (HP)........................

4.80

4.80

4.80

4.80

4.80

4.80

“1304

2 estimations of a kind specified in item 1301 (SP) 

12.80

12.80

12.80

12.80

12.80

12.80

“1305

2 estimations of a kind specified in item 1302 (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1306

2 estimations of a kind specified in item 1303 (HP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1307

3 to 5 estimations of a kind specified in item 1301 (SP)

16.00

16.00

16.00

16.00

16.00

16.00

“1308

3 to 5 estimations of a kind specified in item 1302 (OP)

12.00

12.00

12.00

12.00

12.00

12.00

“1309

3 to 5 estimations of a kind specified in item 1303 (HP)

8.00

8.00

8.00

8.00

8.00

8.00

“1310

6 or more estimations of a kind specified in item 1301 (SP) 

17.60

17.60

17.60

17.60

17.60

17.60

“1311

6 or more estimations of a kind specified in item 1302 (OP) 

13.20

13.20

13.20

13.20

13.20

13.20

“1312

6 or more estimations of a kind specified in item 1303 (HP) 

8.80

8.80

8.80

8.80

8.80

8.80

“1319

Qualitative estimation of- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-one estimation (SP)...............

3.20

3.20

3.20

3.20

3.20

3.20

“1320

Qualitative estimation of- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-one estimation (OP)..............

2.40

2.40

2.40

2.40

2.40

2.40

“1322

2 or more estimations to which item 1319 applies (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1323

2 or more estimations to which item 1320 applies (OP)

4.80

4.80

4.80

4.80

4.80

4.80

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1327

Qualitative estimation of— foetoprotein, gastric acidity (by dye method) or porphyrins—each estimation (SP)..........

12.80

12.80

12.80

12.80

12.80

12.80

“1328

Qualitative estimation of—foetoprotein, gastric acidity (by dye method) or porphyrins—each estimation (OP).........

9.60

9.60

9.60

9.60

9.60

9.60

“1330

Chromatography, qualitative estimation of a substance not specified in any other item in this Division (SP).................

12.80

12.80

12.80

12.80

12.80

12.80

“1331

Chromatography, qualitative estimation of a substance not specified in any other item in this Division (OP).................

9.60

9.60

9.60

9.60

9.60

9.60

“1333

Electrophoresis, qualitative (SP)...................

12.80

12.80

12.80

12.80

12.80

12.80

“1334

Electrophoresis, qualitative (OP)..................

9.60

9.60

9.60

9.60

9.60

9.60

“1336

Australia antigen or similar antigen, detection of by any method including radioimmunoassay (SP)............................

12.80

12.80

12.80

12.80

12.80

12.80

“1337

Australia antigen or similar antigen, detection of by any method including radioimmunoassay (OP)...........................

9.60

9.60

9.60

9.60

9.60

9.60

“1339

Osmolality, estimation of in serum or urine (SP) 

12.80

12.80

12.80

12.80

12.80

12.80

“1340

Osmolality, estimation of in serum or urine (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1342

Quantitative estimation of—acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement fraction, any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose—each estimation (SP)...................

12.80

12.80

12.80

12.80

12.80

12.80

“1343

Quantitative estimation of—acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement fraction, any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose—each estimation (OP)...................

9.60

9.60

9.60

9.60

9.60

9.60

“1345

Quantitative estimation of—arsenic, copper, gold, lead, mercury, strontium, zinc, folic acid, vitamin B12, alcohol, ammonia, neo-natal bilirubin (direct and indirect), cholinesterase, coproporphyrin, uroporphyrin, any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any other substance not specified in any other item in this Division—each estimation (SP)...............................................................

19.20

19.20

19.20

19.20

19.20

19.20

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1346

Quantitative estimation of—arsenic, copper, gold, lead, mercury, strontium, zinc, folic acid, vitamin B12, alcohol, ammonia, neo-natal bilirubin (direct and indirect), cholinesterase, coproporphyria uroporphyrin, any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any substance not specified in any other item in this Division—each estimation (OP)............................................

14.40

14.40

14.40

14.40

14.40

14.40

“1348

Dibucaine number or similar, determination of (SP) 

19.20

19.20

19.20

19.20

19.20

19.20

“1349

Dibucaine number or similar, determination of (OP) 

14.40

14.40

14.40

14.40

14.40

14.40

“1351

Indican, Qualitative test for (SP)........................

19.20

19.20

19.20

19.20

19.20

19.20

“1352

Indican, qualitative test for (OP)........................

14.40

14.40

14.40

14.40

14.40

14.40

“1354

Calculus, analysis of (SP).................................

19.20

19.20

19.20

19.20

19.20

19.20

“1355

Calculus, analysis of (OP).................................

14.40

14.40

14.40

14.40

14.40

14.40

“1357

Amniotic fluid, spectrophotometric analysis of (SP) 

19.20

19.20

19.20

19.20

19.20

19.20

“1358

Amniotic fluid, sepctrophotometric analysis of (OP) 

14.40

14.40

14.40

14.40

14.40

14.40

“1360

Electrophoresis, quantitative (including qualitative test) (SP) 

19.20

19.20

19.20

19.20

19.20

19.20

“1362

Electrophoresis, quantitative (including qualitative test) (OP) 

14.40

14.40

14.40

14.40

14.40

14.40

“1364

Quantitative estimation of—catecholamines (each component), faecal fat, HMMA, hydroxyproline, blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH), non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction), or multiple steroid fractions estimated in the same process—each estimation (SP)

25.50

25.50

25.50

25.50

25.50

25.50

“1366

Quantitative estimation of— catecholamines (each component), faecal fat, HMMA, hydroxyproline, blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH), non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction), or multiple steroid fractions estimated in the same process—each estimation (OP)

19.15

19.15

19.15

19.15

19.15

19.15

“1368

Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

“1370

Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (OP) 

19.15

19.15

19.15

19.15

19.15

19.15

“1372

Lecithin/sphingomyelin ratio of amniotic fluid, determination of (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1374

Lecithin/sphingomyelin ratio of amniotic fluid, determination of (OP) 

19.15

19.15

19.15

19.15

19.15

19.15

“1376

Drug assays—qualitative estimations or screening procedures—one or more estimations or procedures on each specimen (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1378

Drug assays—qualitative estimations or screening procedures—one or more estimations or procedures on each specimen (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“1380

Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin—estimation of one substance by one or more methods (SP) 

16.00

16.00

16.00

16.00

16.00

16.00

“1381

Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin—estimation of one substance by one or more methods (OP) 

12.00

12.00

12.00

12.00

12.00

12.00

“1382

Estimation of two substances referred to in item 1380 by using one or more of the methods specified in that item in relation to each (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

“1384

Estimation of two substances referred to in item 1381 by using one or more of the methods specified in that item in relation to each (OP) 

19.15

19.15

19.15

19.15

19.15

19.15

“1385

Estimation of three or more substances referred to in item 1380 by using one or more of the methods specified in that item in relation to each (SP) 

32.00

32.00

32.00

32.00

32.00

32.00

“1387

Estimation of three or more substances referred to in item 1381 by using one or more of the methods specified in that item in relation to each (OP) 

24.00

24.00

24.00

24.00

24.00

24.00

“1392

Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and item 1393— estimation of one substance by one or more methods (SP) 

19.20

19.20

19.20

19.20

19.20

19.20

“1393

Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and item 1392 -estimation of one substance by one or more methods (OP) 

14.40

14.40

14.40

14.40

14.40

14.40

“1394

Estimation of two substances referred to in item 1392 by using one or more of the methods specified in that item in relation to each (SP) 

32.00

32.00

32.00

32.00

32.00

32.00

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1395

Estimation of two substances referred to in item 1393 by using one or more of the methods specified in that item in relation to each (OP) 

24.00

24.00

24.00

24.00

24.00

24.00

“1397

Estimation of three or more substances referred to in item 1392 by using one or more of the methods specified in that item in relation to each (SP)....................................................................

38.50

38.50

38.50

38.50

38.50

38.50

“1398

Estimation of three or more substances referred to in item 1393 by using one or more of the methods specified in that item in relation to each (OP)....................................................................

28.90

28.90

28.90

28.90

28.90

28.90

“Hormone Assays not covered by any other item in this Division

“1419

Assay of thryoxine (T4) or T3 resin uptake (or equivalent function test)— using any technique (SP)........................................

9.60

9.60

9.60

9.60

9.60

9.60

“1420

Assay of thyroxine (T4) or T3 resin uptake (or equivalent function test)— using any technique (OP).......................................

7.20

7.20

7.20

7.20

7.20

7.20

“1427

Assay of thyroxine (T4) and T3 resin uptake (or equivalent function test)— using any technique (SP)...............................

16.00

16.00

16.00

16.00

16.00

16.00

“1428

Assay of thyroxine (T4) and T3 resin uptake (or equivalent function test)— using any technique (OP)...............................

12.00

12.00

12.00

12.00

12.00

12.00

“1434

Assay of normalised thyroxine (effective thyroxine ratio) or similar assay—when not associated with a procedure to which item 1419 or 1427 applies— assay using any technique (SP).......................

12.80

12.80

12.80

12.80

12.80

12.80

“1435

Assay of normalised thyroxine (effective thyroxine ratio) or similar assay—when not associated with a procedure to which item 1420 or 1428 applies— assay using any technique (OP)......................

9.60

9.60

9.60

9.60

9.60

9.60

“1441

Assay of thyroxine (T4), T3 resin uptake (or equivalent function test) and normalised thyroxine (effective thyroxine ratio) orsimilar assay performed by a different procedure—assay using any technique (SP) 

22.50

22.50

22.50

22.50

22.50

22.50

“1442

Assay of thyroxine (T4), T3 resin uptake (or equivalent function test) and normalised thyroxine (effective thyroxine ratio) or similar assay performed by a different procedure—assay using any technique (OP) 

16.90

16.90

16.90

16.90

16.90

16.90

“1452

Hormone assays using gamma emitting labels or any other unspecified technique (excluding thyroid hormones covered by items 1419, 1427, 1434 and 1441)—one estimation of any one hormone (SP)

19.20

19.20

19.20

19.20

19.20

19.20

“1453

Hormone assays using gamma emitting labels or any other unspecified technique (excluding thyroid hormones covered by items 1420, 1428, 1435 and 1442)—one estimation of any one hormone (OP)

14.40

14.40

14.40

14.40

14.40

14.40

“1455

2 estimations of any one hormone using any technique referred to in item 1452 (SP).............................................................

29.00

29.00

29.00

29.00

29.00

29.00

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1456

2 estimations of any one hormone using any technique referred to in item 1453 (OP)............................

21.75

21.75

21.75

21.75

21.75

21.75

“1458

3 estimations of any one hormone using any technique referred to in item 1452 (SP)............................

38.50

38.50

38.50

38.50

38.50

38.50

“1459

3 estimations of any one hormone using any technique referred to in item 1453 (OP)............................

28.90

28.90

28.90

28.90

28.90

28.90

“1461

Each estimation of any one hormone in excess of three estimations using any technique referred to in item 1452 (SP)...................................................

3.90

3.90

3.90

3.90

3.90

3.90

“1462

Each estimation of any one hormone in excess of three estimations using any technique referred to in item 1453 (OP)..........................................................

2.95

2.95

2.95

2.95

2.95

2.95

“1475

Hormone assay using beta emitting labels or bioassay techniques—one estimation of any one hormone (SP)

32.00

32.00

32.00

32.00

32.00

32.00

“1476

Hormone assay using beta emitting labels or bioassay techniques—one estimation of any one hormone (OP)

24.00

24.00

24.00

24.00

24.00

24.00

“1478

Hormone assays using beta emitting labels or bioassay techniques—two estimations of any one hormone (SP)

51.00

51.00

51.00

51.00

51.00

51.00

“1479

Hormone assays using beta emitting labels or bioassay techniques—two estimations of any one hormone (OP)

38.25

38.25

38.25

38.25

38.25

38.25

“1481

Hormone assays using beta emitting labels or bioassay techniques—three estimations of any one hormone (SP)

64.00

64.00

64.00

64.00

64.00

64.00

“1482

Hormone assays using beta emitting labels or bioassay techniques—three estimations of any one hormone (OP) 

48.00

48.00

48.00

48.00

48.00

48.00

“1484

Hormone assays using beta emitting labels or bioassay techniques—each estimation of any one hormone in excess of three (SP)...........................................

6.40

6.40

6.40

6.40

6.40

6.40

“1485

Hormone assays using beta emitting labels or bioassay techniques—each estimation of any one hormone in excess of three (OP)..........................................

4.80

4.80

4.80

4.80

4.80

4.80

“Procedural Services

“1504

Procedural services associated with— ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, 1-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1505

Procedural services associated with— ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, 1-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“1511

Procedural services associated with— tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (SP).........................

19.20

19.20

19.20

19.20

19.20

19.20

“1512

Procedural services associated with— tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification, test, or any similar test (OP)........................

14.40

14.40

14.40

14.40

14.40

14.40

“11516

Procedural services associated with the administration of—thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (SP)............................

16.00

16.00

16.00

16.00

16.00

16.00

“1517

Procedural services associated with the administration of—thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (OP)...........................

12.00

12.00

12.00

12.00

12.00

12.00

““Division 3—Microbiology

“1529

Microscopical examination, wet film, not covered by item 1536 (SP).................................................................

3.90

3.90

3.90

3.90

3.90

3.90

“1530

Microscopical examination, wet film, not covered by item 1537 (OP).................................................................

2.95

2.95

2.95

2.95

2.95

2.95

“1536

Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP)......................................

5.10

5.10

5.10

5.10

5.10

5.10

“1537

Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (where the patient is referred by another medical practitioner) (OP).......................................

3.85

3.85

3.85

3.85

3.85

3.85

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1545

Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—one stain (SP).

5.10

5.10

5.10

5.10

5.10

5.10

“1546

Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa) —one stain (OP)

3.85

3.85

3.85

3.85

3.85

3.85

“1548

Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—two or more stains (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1549

Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—two or more stains (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“1556

Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)—one stain (SP)..................

6.40

6.40

6.40

6.40

6.40

6.40

“1557

Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)—one stain (OP).................

4.80

4.80

4.80

4.80

4.80

4.80

“1566

Microscopical examination using 2 or more stains, one or more of which is a special stain referred to in item 1556 (SP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1567

Microscopical examination using 2 or more stains, one or more of which is a special stain referred to in item 1557 (OP) 

7.20

7.20

7.20

7.20

7.20

7.20

“1586

Microscopical examination for dermatophytes—examination of material from one site (SP)..................................

6.40

6.40

6.40

6.40

6.40

6.40

“1587

Microscopical examination for dermatophytes—examination of material from one site (OP).................................

4.80

4.80

4.80

4.80

4.80

4.80

“1588

Microscopical examination for dermatophytes—examination of material from 2 or more sites (SP)........................

12.80

12.80

12.80

12.80

12.80

12.80

“1589

Microscopical examination for dermatophytes—examination of material from 2 or more sites (OP).......................

9.60

9.60

9.60

9.60

9.60

9.60

“1604

Microscopical examination of exudate by dark ground illumination for Treponema pallidum (SP)

16.00

16.00

16.00

16.00

16.00

16.00

“1606

Microscopical examination of exudate by dark ground illumination for Treponema pallidum (OP)......................

12.00

12.00

12.00

12.00

12.00

12.00

“1609

Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (SP).....................................

12.80

12.80

12.80

12.80

12.80

12.80

“1610

Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (OP)....................................

9.60

9.60

9.60

9.60

9.60

9.60

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1611

Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (HP)............

8.10

8.10

8.10

8.10

8.10

8.10

“1615

Cultural examination of a specimen other then blood or urine for aerobic and anaerobic micro-organisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (SP)

19.20

19.20

19.20

19.20

19.20

19.20

“1616

Cultural examination of a specimen other than blood or urine for aerobic and anaerobic micro-organisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (OP)

14.40

14.40

14.40

14.40

14.40

14.40

“1618

Cultural examination of a specimen other than blood or urine for aerobic and anaerobic micro-organisms, using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (HP)

12.10

12.10

12.10

12.10

12.10

12.10

“1622

Cultural examination for mycobacteria— each specimen (SP).........................................................

12.80

12.80

12.80

12.80

12.80

12.80

“1623

Cultural examination for mycobacteria— each specimen (OP).........................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1633

Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of 3 sets (SP).....................

19.20

19.20

19.20

19.20

19.20

19.20

“1634

Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of three sets (OP) 

14.40

14.40

14.40

14.40

14.40

14.40

“1636

Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of three sets (HP) 

9.60

9.60

9.60

9.60

9.60

9.60

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1644

Identification of pathogenic microorganisms using biochemical tests or other special techniques involving subculture or biochemical tests and other special techniques involving subculture—identification of one organism (SP)...........................................

6.40

6.40

6.40

6.40

6.40

6.40

“1645

Identification of pathogenic microorganisms using biochemical tests or other special techniques involving subculture or biochemical tests and other special techniques involving subculture—identification of one organism (OP)..........................................

4.80

4.80

4.80

4.80

4.80

4.80

“1647

Identification of two or more organisms by the method referred to in item 1644 (SP).................................................

12.80

12.80

12.80

12.80

12.80

12.80

“1648

Identification of two or more organisms by the method referred to in item 1645 (OP)................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1661

Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic methods)—a procedure involving one technique (SP)......

6.40

6.40

6.40

6.40

6.40

6.40

“1662

Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic methods)—a procedure involving one technique (OP)......

4.80

4.80

4.80

4.80

4.80

4.80

“1664

2 or more of any procedures of a kind referred to in item 1661 using different techniques (SP)............................

9.60

9.60

9.60

9.60

9.60

9.60

“1665

2 or more of any procedures of a kind referred to in item 1662 using different techniques (OP)...........................

7.20

7.20

7.20

7.20

7.20

7.20

“1673

Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of micro-organisms (not being a service to which item 1682 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP)...........................................

18.00

18.00

18.00

18.00

18.00

18.00

“1674

Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of micro-organisms (not being a service to which item 1683 applies), with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (OP)..........................................

13.50

13.50

13.50

13.50

13.50

13.50

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1676

Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of micro-organisms (not being a service to which item 1682 or 1683 applies) with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (HP)..................................

9.00

9.00

9.00

9.00

9.00

9.00

“1682

Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (SP)..........

6.40

6.40

6.40

6.40

6.40

6.40

“1683

Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (where the patient is referred by another medical practitioner) (OP)............

4.80

4.80

4.80

4.80

4.80

4.80

“1687

Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (SP)..............................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1688

Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (OP)..............................................................

7.20

7.20

7.20

7.20

7.20

7.20

“1693

Identification of helminths (SP)....................

6.40

6.40

6.40

6.40

6.40

6.40

“1694

Identification of helminths (OP)...................

4.80

4.80

4.80

4.80

4.80

4.80

“1702

Cultural examination for parasites, other than trichomonas—culture of one parasite (SP).................................

12.80

12.80

12.80

12.80

12.80

12.80

“1703

Cultural examination for parasites, other than trichomonas—culture of one parasite (OP).................................

9.60

9.60

9.60

9.60

9.60

9.60

“1705

Cultural examination for parasites, other than trichomonas—culture of 2 or more parasites (SP)..............................

22.50

22.50

22.50

22.50

22.50

22.50

“1706

Cultural examination for parasites, other than trichomonas—culture of two or more parasites (OP).......................

16.90

16.90

16.90

16.90

16.90

16.90

“1712

Examination by animal innoculation (SP)......

25.50

25.50

25.50

25.50

25.50

25.50

“1713

Examination by animal innoculation (OP).....

19.15

19.15

19.15

19.15

19.15

19.15

“1721

Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—one organism (SP) 

12.80

12.80

12.80

12.80

12.80

12.80

“1722

Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—one organism (OP)

9.60

9.60

9.60

9.60

9.60

9.60

“1724

Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—two or more organisms (SP)........................................................

16.00

16.00

16.00

16.00

16.00

16.00

“1725

Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique-two or more organisms (OP)..............................................................

12.00

12.00

12.00

12.00

12.00

12.00

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1732

Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (SP).................................

3.20

3.20

3.20

3.20

3.20

3.20

“1733

Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (OP)................................

2.40

2.40

2.40

2.40

2.40

2.40

“1743

Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (SP).........................

12.80

12.80

12.80

12.80

12.80

12.80

“1744

Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (OP)........................

9.60

9.60

9.60

9.60

9.60

9.60

“1760

Agglutination tests (quantitative), including those for enteric fever and brucellosis—one antigen (SP).....................

9.60

9.60

9.60

9.60

9.60

9.60

“1761

Agglutination tests (quantitative), including those for enteric fever and brucellosis—one antigen (OP)....................

7.20

7.20

7.20

7.20

7.20

7.20

“1763

Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen-each antigen (SP) 

5.10

5.10

5.10

5.10

5.10

5.10

“1764

Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen-each antigen (OP) 

3.85

3.85

3.85

3.85

3.85

3.85

“1766

Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of six (SP) 

2.60

2.60

2.60

2.60

2.60

2.60

“1767

Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of six (OP) 

1.95

1.95

1.95

1.95

1.95

1.95

“1772

Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—one test (SP)..........................................................

3.20

3.20

3.20

3.20

3.20

3.20

“1773

Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—one test (OP).........................................................

2.40

2.40

2.40

2.40

2.40

2.40

“1775

Flocculation tests, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (SP)................................

3.90

3.90

3.90

3.90

3.90

3.90

“1776

Flocculation tests, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (OP).................................................

2.95

2.95

2.95

2.95

2.95

2.95

“1781

Complement fixation tests—one test (SP)........

12.80

12.80

12.80

12.80

12.80

12.80

“1782

Complement fixation tests—one test (OP).......

9.60

9.60

9.60

9.60

9.60

9.60

“1784

Complement fixation tests—each test in excess of one (SP) 

3.20

3.20

3.20

3.20

3.20

3.20

“1785

Complement fixation tests—each test in excess of one (OP) 

2.40

2.40

2.40

2.40

2.40

2.40

“1793

Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)— one test (SP)..............................

9.60

9.60

9.60

9.60

9.60

9.60

“1794

Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)— one test (OP).............................

7.20

7.20

7.20

7.20

7.20

7.20

“1796

Each test referred to in item 1793 in excess of one (SP)

5.10

5.10

5.10

5.10

5.10

5.10

“1797

Each test referred to in item 1794 in excess of one (OP)

3.85

3.85

3.85

3.85

3.85

3.85

“1805

Haemagglutination tests—one test (SP)...........

6.40

6.40

6.40

6.40

6.40

6.40

“1806

Haemagglutination tests—one test (OP)..........

4.80

4.80

4.80

4.80

4.80

4.80

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1808

Haemagglutination tests—each test in excess of one (SP) 

3.20

3.20

3.20

3.20

3.20

3.20

“1809

Haemagglutination tests—each test in excess of one (OP) 

2.40

2.40

2.40

2.40

2.40

2.40

“1823

Haemagglutination inhibition tests—one test (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“1824

Haemagglutination inhibition tests—one test (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“1826

Haemagglutination inhibition tests—each test in excess of one (SP)

3.20

3.20

3.20

3.20

3.20

3.20

“1827

Haemagglutination inhibition tests—each test in excess of one (OP)...............................................................

2.40

2.40

2.40

2.40

2.40

2.40

“1843

Antistreptolysin O titre test (SP)...................

9.60

9.60

9.60

9.60

9.60

9.60

“1844

Antistreptolysin O titre test (OP)...................

7.20

7.20

7.20

7.20

7.20

7.20

“1851

Total and differential cell count on any body fluid other than urine (SP)...............................................................

6.40

6.40

6.40

6.40

6.40

6.40

“1852

Total and differential cell count on any body fluid other than urine (OP)...............................................................

4.80

4.80

4.80

4.80

4.80

4.80

“1858

Autogenous vaccine, preparation of— each organism (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

“1859

Autogenous vaccine, preparation of— each organism (OP) 

19.15

19.15

19.15

19.15

19.15

19.15

“Division 4—Immunology

“1877

Immunoelectrophoresis using polyvalent antisera (SP) 

19.20

19.20

19.20

19.20

19.20

19.20

“1878

Immunoelectrophoresis using polyvalent antisera (OP)

14.40

14.40

14.40

14.40

14.40

14.40

“1884

Immunoelectrophoresis using monovalent antiserum—each antiserum (SP)........................................................

3.20

3.20

3.20

3.20

3.20

3.20

“1885

Immunoelectrophoresis using monovalent antiserum—each antiserum (OP)........................................................

2.40

2.40

2.40

2.40

2.40

2.40

“1888

Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of one immunoglobulin (SP)

12.80

12.80

12.80

12.80

12.80

12.80

“1889

Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of one immunoglobulin (OP)...............................

9.60

9.60

9.60

9.60

9.60

9.60

“1891

Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of each immunoglobulin in excess of one (SP).......

6.40

6.40

6.40

6.40

6.40

6.40

“1892

Immunoglobulins, G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of each immunoglobulin in excess of one (OP).......

4.80

4.80

4.80

4.80

4.80

4.80

“1897

Immunoglobulin E, quantitative estimation of (SP) 

19.20

19.20

19.20

19.20

19.20

19.20

“1898

Immunoglobulin E, quantitative estimation of (OP) 

14.40

14.40

14.40

14.40

14.40

14.40

“1903

Radioallergosorbent tests for allergen identification—identification of one to four allergens—each allergen (SP).........

6.40

6.40

6.40

6.40

6.40

6.40

“1904

Radioallergosorbent tests for allergen identification—identification of one to four allergens—each allergen (OP).........

4.80

4.80

4.80

4.80

4.80

4.80

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1905

Radioallergosorbent tests for allergen identification—identification of each allergen in excess of four (SP).....................

3.20

3.20

3.20

3.20

3.20

3.20

“1906

Radioallergosorbent tests for allergen identification—identification of each allergen in excess of four (OP)....................

2.40

2.40

2.40

2.40

2.40

2.40

“1911

Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1918), detection of one antibody (SP).................................................................

12.80

12.80

12.80

12.80

12.80

12.80

“1912

Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1919), detection of one antibody (OP).................................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1913

Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1918), detection of each antibody in excess of one (SP).....................................

6.40

6.40

6.40

6.40

6.40

6.40

“1914

Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1919), detection of each antibody in excess of one (OP).....................................

4.80

4.80

4.80

4.80

4.80

4.80

“1918

Immunofluorescent detection of tissue antibodies, qualitative and quantitative—detection and estimation of each antibody (SP) 

16.00

16.00

16.00

16.00

16.00

16.00

“1919

Immunofluorescent detection of tissue antibodies, qualitative and quantitative—detection and examination of each antibody (OP) 

12.00

12.00

12.00

12.00

12.00

12.00

“1924

Complement fixation tests on human tissue antibodies—one antibody (SP).................................................................

12.80

12.80

12.80

12.80

12.80

12.80

“1925

Complement fixation tests on human tissue antibodies—one antibody (OP).................................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1926

Complement fixation tests on human tissue antibodies—each antibody in excess of one (SP).....................................

6.40

6.40

6.40

6.40

6.40

6.40

“1927

Complement fixation tests on human tissue antibodies—each antibody in excess of one (OP).....................................

4.80

4.80

4.80

4.80

4.80

4.80

“1935

Latex flocculation test—qualitative, quantitative or qualitative and quantitative (SP)........................................

6.40

6.40

6.40

6.40

6.40

6.40

“1936

Latex flocculation test—qualitative, quantitative or qualitative and quantitative (OP).......................................

4.80

4.80

4.80

4.80

4.80

4.80

“1941

Rose Waaler test, quantitative, using sheep cells (SP) 

12.80

12.80

12.80

12.80

12.80

12.80

“1942

Rose Waaler test, quantitative, using sheep cells (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

“1948

Lupus erythematosus cells, preparation and examination of film for (SP).................................................................

9.60

9.60

9.60

9.60

9.60

9.60

“1949

Lupus erythematosus cells, preparation and examination of film for (OP).................................................................

7.20

7.20

7.20

7.20

7.20

7.20

“1955

Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (SP)............................................

12.80

12.80

12.80

12.80

12.80

12.80

“1956

Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (OP)...........................................

9.60

9.60

9.60

9.60

9.60

9.60

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“1957

Tanned erythrocyte haemagglutination test for tissue antibodies—each antibody in excess of one (SP)..................

6.40

6.40

6.40

6.40

6.40

6.40

“1958

Tanned erythrocyte haemagglutination test for tissue antibodies—each antibody in excess of one (OP)..................

4.80

4.80

4.80

4.80

4.80

4.80

“1965

Leucocyte fractionation as preliminary test to specific tests of leucocyte function by density gradient centrifugation or any other method (SP)...............................................................

19.20

19.20

19.20

19.20

19.20

19.20

“1966

Leucocyte fractionation as preliminary test to specific tests of leucocyte function by density gradient centrifugation or any other method (OP)...............................................................

14.40

14.40

14.40

14.40

14.40

14.40

“1971

Neutrophil function tests for phagocytic activity—visual techniques (SP)........................................................

19.20

19.20

19.20

19.20

19.20

19.20

“1972

Neutrophil function tests for phagocytic activity—visual techniques (OP).......................................................

14.40

14.40

14.40

14.40

14.40

14.40

“1973

Neutrophil function tests for phagocytic activity—radioactive techniques (SP).......................................

32.00

32.00

32.00

32.00

32.00

32.00

“1974

Neutrophil function tests for phagocytic activity—radioactive techniques (OP).......................................

24.00

24.00

24.00

24.00

24.00

24.00

“1981

Lymphocyte cell count—E. rosette technique or similar (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

“1982

Lymphocyte cell count—E. rosette tech-nique or similar (OP)

19.15

19.15

19.15

19.15

19.15

19.15

“1987

B lymphocyte cell count—by immunofluorescence or immuno-peroxidase (SP).......................................

25.50

25.50

25.50

25.50

25.50

25.50

“1988

B lymphocyte cell count —by immunofluorescence or immuno-peroxidase (OP)......................................

19.15

19.15

19.15

19.15

19.15

19.15

“1995

Lymphocyte function test—visual transformation (SP) 

25.50

25.50

25.50

25.50

25.50

25.50

“1996

Lymphocyte function test—visual transformation (OP)

19.15

19.15

19.15

19.15

19.15

19.15

“1997

Lymphocyte function test—radioactive techniques (SP)

38.50

38.50

38.50

38.50

38.50

38.50

“1998

Lymphocyte function text — radioactive techniques (OP) 

28.90

28.90

28.90

28.90

28.90

28.90

“2006

Tissue group typing (HLA phenotyping) (SP)

32.00

32.00

32.00

32.00

32.00

32.00

“2007

Tissue group typing (HLA phenotyping) (OP)

24.00

24.00

24.00

24.00

24.00

24.00

“2013

Skin sensitivity testing (Mantoux, Schick, Casoni or similar test)—each test (SP)..................................................

6.40

6.40

6.40

6.40

6.40

6.40

“2014

Skin sensitivity testing (Mantoux, Schick, Casoni or similar test)—each test (OP).................................................

4.80

4.80

4.80

4.80

4.80

4.80

“2022

Skin sensitivity—induction and detection of sensitivity to chemical antigens (SP)...........................................

12.80

12.80

12.80

12.80

12.80

12.80

“2023

Skin sensitivity—induction and detection of sensitivity to chemical antigens (OP)..........................................

9.60

9.60

9.60

9.60

9.60

9.60

“Division 5—Histopathology

“2041

Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (SP).........................

45.00

45.00

45.00

45.00

45.00

45.00

“2042

Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (OP).........................

33.75

33.75

33.75

33.75

33.75

33.75

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“2048

Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP)...............................................................

58.00

58.00

58.00

58.00

58.00

58.00

“2049

Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP)...............................................................

43.50

43.50

43.50

43.50

43.50

43.50

“2056

Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) 

83.00

83.00

83.00

83.00

83.00

83.00

“2057

Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) 

62.25

62.25

62.25

62.25

62.25

62.25

“Division 6—Cytology

“2081

Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane—each examination (SP)

9.60

9.60

9.60

9.60

9.60

9.60

“2082

Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane—each examination (OP)

7.20

7.20

7.20

7.20

7.20

7.20

“2091

Cytological examination for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid—each examination (SP).....

19.20

19.20

19.20

19.20

19.20

19.20

“2092

Cytological examination for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid—each examination (OP).....

14.40

14.40

14.40

14.40

14.40

14.40

“2096

Cytological examination for malignant cells—examination of gastric washings, duodenal washings, oesophageal washings or colonic washings—each examination (SP).........

25.50

25.50

25.50

25.50

25.50

25.50

“2097

Cytological examination for malignant cells—examination of gastric washings, duodenal washings, oesophageal washings or colonic washings—each examination (OP).........

19.15

19.15

19.15

19.15

19.15

19.15

“2104

Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) 

9.60

9.60

9.60

9.60

9.60

9.60

“2105

Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) 

7.20

7.20

7.20

7.20

7.20

7.20

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“2111

Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) 

16.00

16.00

16.00

16.00

16.00

16.00

“2112

Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) 

12.00

12.00

12.00

12.00

12.00

12.00

“Division 7—Cytogenetics

“2131

Cytological sex determination from blood film (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“2132

Cytological sex determination from blood film (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“2141

Cytological sex chromatin studies (Barr or Y bodies)—other than from blood film—each tissue examined (SP)......

6.40

6.40

6.40

6.40

6.40

6.40

“2142

Cytological sex chromatin studies (Barr or Y bodies)—other than from blood film—each tissue examined (OP).....

4.80

4.80

4.80

4.80

4.80

4.80

“2148

Chromosome studies, including preparation, count and karyotyping of omniotic fluid (SP)..............................

96.00

96.00

96.00

96.00

96.00

96.00

“2149

Chromosome studies, including preparation, count and karyotyping of amniotic fluid (OP)..............................

72.00

72.00

72.00

72.00

72.00

72.00

“2155

Chromosome studies, including preparation, count and karyotyping of bone marrow (SP)...............................

64.00

64.00

64.00

64.00

64.00

64.00

“2156

Chromosome studies, including preparation, count and karyotyping of bone marrow (OP)

48.00

48.00

48.00

48.00

48.00

48.00

“2161

Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in item 2148 or 2155—each study (SP)............................

77.00

77.00

77.00

77.00

77.00

77.00

“2162

Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in item 2149 or 2156-each study (OP)......................................

57.75

57.75

57.75

57.75

57.75

57.75

“2170

Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (SP) 

64.00

64.00

64.00

64.00

64.00

64.00

“2171

Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (OP)

48.00

48.00

48.00

48.00

48.00

48.00

“2173

Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (SP) 

96.00

96.00

96.00

96.00

96.00

96.00

“2174

Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (OP) 

72.00

72.00

72.00

72.00

72.00

72.00

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

Division 8—Infertility and Pregnancy Tests

“2201

Examination of semen for presence of spermatozoa (SP) 

3.90

3.90

3.90

3.90

3.90

3.90

“2202

Examination of semen for presence of spermatozoa (OP) 

2.95

2.95

2.95

2.95

2.95

2.95

“2211

Huhner’s test (post-coital test) — collection of sample and examination of wet preparation (SP)......

12.80

12.80

12.80

12.80

12.80

12.80

“2212

Huhner’s test (post-coital test) — collection of sample and examination of wet preparation (OP).....

9.60

9.60

9.60

9.60

9.60

9.60

“2215

Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (SP)

19.20

19.20

19.20

19.20

19.20

19.20

“2216

Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (OP)

14.40

14.40

14.40

14.40

14.40

14.40

“2225

Chemical analysis of semen—analysis of one substance (SP) 

9.60

9.60

9.60

9.60

9.60

9.60

“2226

Chemical analysis of semen—analysis of one substance (OP) 

7.20

7.20

7.20

7.20

7.20

7.20

“2227

Chemical analysis of semen—analysis of two or more substances (SP)...........................................................

16.00

16.00

16.00

16.00

16.00

16.00

“2228

Chemical analysis of semen—analysis of two or more substances (OP)...........................................................

12.00

12.00

12.00

12.00

12.00

12.00

“2247

Spermagglutinating and immobilising antibodies, test for—one test (SP)....................................................

9.60

9.60

9.60

9.60

9.60

9.60

“2248

Spermagglutinating and immobilising antibodies, test for—one test (OP)...................................................

7.20

7.20

7.20

7.20

7.20

7.20

“2249

Two or more tests referred to in item 2247 (SP) 

12.80

12.80

12.80

12.80

12.80

12.80

“2250

Two or more tests referred to in item 2248 (OP) 

9.60

9.60

9.60

9.60

9.60

9.60

“2264

Sperm penetrability, one or more tests for (SP) 

6.40

6.40

6.40

6.40

6.40

6.40

“2265

Sperm penetrability, one or more tests for (OP) 

4.80

4.80

4.80

4.80

4.80

4.80

“2272

Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods (SP)....................................................

6.40

6.40

6.40

6.40

6.40

6.40

“2273

Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods (OP)...................................................

4.80

4.80

4.80

4.80

4.80

4.80

“2285

Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in item 2272) (SP)....................................................

19.20

19.20

19.20

19.20

19.20

19.20

“2286

Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in item 2273) (OP)...................................................

14.40

14.40

14.40

14.40

14.40

14.40

 

Fees

Item No.

Medical service

N.S.W.

Vic.

Qld

S.A.

W.A.

Tas.

$

$

$

$

$

$

“Division 9—Simple Basic Pathology Tests

“2334

Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-one procedure................................

1.95

1.95

1.95

1.95

1.95

1.95

“2335

Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-two procedures..............................

2.95

2.95

2.95

2.95

2.95

2.95

“2336

Blood count consisting of leucocyte count, erythrocite sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-three or more procedures................

3.85

3.85

3.85

3.85

3.85

3.85

“2342

Microscopical examination of urine.

1.95

1.95

1.95

1.95

1.95

1.95

“2346

Pregnancy test by one or more immunochemical methods......................................................

4.80

4.80

4.80

4.80

4.80

4.80

“2352

Microscopical examination of wet film other than urine......................................................

2.95

2.95

2.95

2.95

2.95

2.95

“2357

Microscopical examination of gram stained film 

3.85

3.85

3.85

3.85

3.85

3.85

“2362

Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method.......

1.00

1.00

1.00

1.00

1.00

1.00

“2369

Microscopical examination screening for fungi in skin, hair or nails—one or more sites...........

2.95

2.95

2.95

2.95

2.95

2.95

“2374

Mantoux test.....................................

4.80

4.80

4.80

4.80

4.80

4.80

“2382

Casoni test for hydatid disease.........

4.80

4.80

4.80

4.80

4.80

4.80

“2388

Schick test........................................

4.80

4.80

4.80

4.80

4.80

4.80

“2392

Seminal examination for presence of spermatozoa......................................................

2.95

2.95

2.95

2.95

2.95

2.95”.

NOTE

1. Notified in the Commonwealth of Australia Gazette

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0